JPMorgan marks 1,000th branch opening since 2018 expansion plans
The bank is marking the milestone opening in Charlotte, North Carolina, on Thursday where Chairman and CEO Jamie Dimon is attending a ribbon-cutting ceremony. The firm has roughly 5,000 branches, the most of any American bank, according to Federal Reserve data from March.
"It's a great marker for us to be able to say, you can see our commitment over time and we're on a marathon with regard to this expansion," said Jennifer Roberts, the CEO of Chase Consumer Banking, in an interview. "A thousand [branches] is significant – a thousand is bigger than many regional competitors have at all."
In 2018, JPMorgan operated bank branches in 23 U.S. states and said it would expand into as many as 20 new markets over the following five years with about 400 new locations. By 2021, the firm said it had branches in all 48 lower states. And last February, JPMorgan announced a new, multibillion-dollar investment to open another 500 new locations by 2027.
JPMorgan said over the past seven years, Chase has opened more bank branches than all of its large bank peers combined. However, many of JPMorgan's competitors have recently announced plans to expand their own footprints as the quest for deposits heats up.
Bank of America recently announced a branch expansion, with plans to open 150 new centers by 2027. And Wells Fargo plans to add branches, especially now that it's fulfilled a regulatory consent order that had been constraining its growth.
The industry-wide growth plans could help reverse a trend dating back to the 2008 financial crisis in which the U.S. has seen the net number of bank branches plummet. The combination of fewer overall banks and the advent of online banking has broadly made brick-and-mortar locations lower priority. However, in recent years, especially amid the population migration during and after the pandemic, banks have been reorienting their footprints to capture more deposits.
Expanding in Charlotte puts JPMorgan head-to-head with rival Bank of America, which is headquartered there and has 71% market share in the city, according to KBW and S&P Global Market Intelligence data.
Roberts said after this latest opening, Chase will have about 75 branches in North Carolina. She said that the bank is expanding there due to its "young, fast-growing population" and that there's a "lot of wealth coming into that area" as well.
JPMorgan said at its investor day in May that its newer branches are expected to ultimately contribute more than $160 billion in incremental deposits. The firm said each new branch breaks even within four years.
JPMorgan said when its expansion is complete, Chase will have added more than 1,100 branches, renovated 4,300 locations and entered 80 new markets. It also expects that 75% of the U.S. population will be able to reach one of its branches within an "accessible drive."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
11 minutes ago
- Axios
DMV employers jump on pet benefits trend for fur baby parents
Washington companies are jumping on the "fur baby" trend and providing pet bennies to their employees. The big picture: As people continue to delay having children, more owners are considering their fuzzy offspring part of the fam. 94 million American households have a pet, per the American Pet Products Association, and they'll spend a projected $41.4 billion this year on vet care and pet products. State of play: Tysons-based Hilton offers pet insurance and, starting next month, employees will be able to access pet services through its concierge partnership with Wellthy, a spokesperson tells Axios. Think: help finding groomers, vets, boarding spots or doggie-friendly housing. Or, assistance setting up recurring food or prescription deliveries, or with understanding pet insurance claims. Companies with local footprints like Adobe, Blue Cross Blue Shield, John Hancock, Lyft and Workday partner with pet care group Airvet for free 24/7 virtual vet help and discounts on pet insurance, wellness plans, and backup care via resources like Rover, an Airvet spokesperson says. And at Google, workers can bring their furry pals (aka Dooglers) to the office and get discounts on pet insurance through the group Perks at Work, a spokesperson tells Axios. The intrigue: The number of D.C.-area clients Airvet works with jumped 267% between 2023 and 2024, per the spokesperson. What they're saying: Finding a company where pets are supported as part of an employee's family can be a deciding factor for some when choosing a gig, Airvet CEO Brandon Werber says. Many of Airvets' clients say their pet benefits are the highest used and fastest growing option they offer outside of regular health insurance, Werber tells Axios. While offering these types of benefits is a good way for companies to attract and retain the Gen Z and Millennial fur baby parents, says Werber, the appeal has been far more wide reaching than they expected. By the numbers: 32% of fur parents said having pet benefits would incentivize them to stay at their job, or to look for another that offers them, according to a 2021 survey led by Nationwide.
Business Insider
12 minutes ago
- Business Insider
Africa's richest country hit with 30% US tariff after trade talks fail
South Africa is set to face a 30% tariff on its exports to the United States starting next week, after failing to secure a trade agreement before the deadline. South Africa will face a 30% tariff on exports to the U.S. as part of a broader trade adjustment policy. The tariffs, set to take effect next week, will impact automotive, agro-processing, steel, and chemical sectors. Negotiations to prevent the tariffs included $3.3 billion in proposed investments, which ultimately fell short. South Africa is set to face a 30% tariff on its exports to the United States starting next week, after failing to secure a trade agreement before a deadline imposed by former U.S. President Donald Trump. The tariffs, outlined in an executive order signed Thursday, will apply to dozens of countries, with rates ranging between 10% and 41%. The measures take effect in seven days as part of Trump's broader push to renegotiate trade relationships in favour of the U.S., Reuters reported. Pretoria had been negotiating for months to avert the tariff hike, proposing to buy U.S. liquefied natural gas and pledging $3.3 billion in investments into American industries. But those overtures fell short, even after a last-minute attempt to sweeten the deal. South African Trade Minister Parks Tau called the tariff escalation a direct threat to the country's export-driven sectors, particularly automotive manufacturing, agro-processing, steel, and chemicals. The U.S. is South Africa's second-largest bilateral trading partner after China. Key South African exports to the U.S. include vehicles, iron and steel products, and citrus fruits. Political tensions cloud trade talks Relations between South Africa and the United States have sharply declined since Donald Trump returned to the White House in January. The fallout reflects deeper strains in U.S.-South Africa relations. According to South African officials, trade negotiations were entangled with political frictions, most notably Washington's disapproval of South Africa's affirmative action policies, its land reform agenda, and its decision to bring a genocide case against Israel, a close U.S. ally, before the International Court of Justice. Trump, who has repeatedly criticised South Africa's policies, has falsely accused the government of forcibly seizing land from white farmers. In response, the South African government defended its stance, calling the land reform effort a constitutional measure aimed at addressing historical racial inequalities in land ownership dating back to apartheid. Officials also stressed that, contrary to international speculation, no land expropriations have occurred.
CNBC
12 minutes ago
- CNBC
Trump's drug price ultimatum sets pharma firms scrambling
Pharmaceutical firms are scrambling to respond to a fresh ultimatum from U.S. President Donald Trump demanding "binding commitments" to lower their drug prices stateside . The White House said Thursday that President Trump had sent letters to 17 major pharmaceutical firms outlining the steps they must take to lower the price of U.S. prescription drugs to "most favored nation" (MFN) levels by Sept. 29. They were told that if they "refuse to step up," the government will deploy every tool in its "arsenal to protect American families from continued abusive drug pricing practices," without stating what those measures could be. The companies to receive letters were AbbVie , Amgen , AstraZeneca , Boehringer Ingelheim, Bristol-Myers Squibb , Eli Lilly , EMD Serono, Roche' s subsidiary Genentech, Gilead , GSK , Johnson & Johnson , Merck , Novartis , Novo Nordisk , Pfizer , Regeneron and Sanofi . Healthcare stocks tumbled Friday, following broader market losses as investors digested Trump's amended trade tariffs. Shares of Wegovy-maker Novo Nordisk dropped 5% in early morning trade before paring losses to trade 1.3% lower at 11:15 a.m. London time (6:15 a.m. ET). Companies were informed that they must provide MFN prices to all Medicaid patients, the U.S. health program for low-income patients. They were also told not to offer medicines to other developed markets at better prices than those offered in the U.S., and that they should sell drugs directly to U.S. patients, thereby cutting out pharmacy middlemen known as pharmacy benefit managers (PBMs). Trump has long lambasted pharmaceutical firms for what he dubs are unfair pricing practices, previously saying that he planned to bring down U.S. prices by 80%. In May, the president signed an executive order to lower drug costs by tying the prices of some medicines in the U.S. to the significantly lower ones abroad under the MFN policy. The U.S. consistently pays the most in the world for many prescription drugs, due in part to the U.S.′ highly complex and fragmented reimbursement system and lack of national pricing control. The latest announcement comes as the pharmaceutical industry is also calling for clarity on potential industry-wide tariffs. Trump previously warned these could run as high as 200%. Many companies have nevertheless shared that they agree with some of Trump's concerns. AstraZeneca CEO Pascal Soriot said Tuesday that the Anglo-Swedish firm had been liaising closely with the U.S. administration over the MFN policy and investment in U.S. manufacturing more broadly. Last week, it announced plans to invest $50 billion in the U.S., following a slew of other pharma firms. "There are issues around prices. I personally believe the president is right to say price equalization should happen," Soriot told reporters on an earnings call. Vas Narasimhan, CEO of Swiss-headquartered Novartis, also said last month that the firm was pursuing an MFN policy to lower U.S. drug prices. JPMorgan analysts said in a note Friday that while the latest announcement was intended to serve as a stark warning, ongoing talks between with the U.S. administration could buy pharma firms some time to respond. "While the government's latest announcement may appear harsh, we think it is likely that the matter is being discussed to some extent between the companies and the government, and we believe no changes that would have a significant negative impact on pharmaceutical companies will occur in the short term," analysts led by Seiji Wakao said in a note to clients.
